CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes

Techniques that enable longitudinal tracking of cell fate after myocardial delivery are imperative for optimizing the efficacy of cell‐based cardiac therapies. However, these approaches have been underutilized in preclinical models and clinical trials, and there is considerable demand for site‐speci...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Stem Cells Transl Med
Glavni autori: Ostrominski, John W., Yada, Ravi Chandra, Sato, Noriko, Klein, Michael, Blinova, Ksenia, Patel, Dakshesh, Valadez, Racquel, Palisoc, Maryknoll, Pittaluga, Stefania, Peng, Kah‐Whye, San, Hong, Lin, Yongshun, Basuli, Falguni, Zhang, Xiang, Swenson, Rolf E., Haigney, Mark, Choyke, Peter L., Zou, Jizhong, Boehm, Manfred, Hong, So Gun, Dunbar, Cynthia E.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Enabling Technologies for Cell‐based Clinical Translation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519772/
https://ncbi.nlm.nih.gov/pubmed/32700830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0019
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items